Abbott Laboratories (ETR:ABL)
109.02
+1.60 (1.49%)
Nov 7, 2025, 5:35 PM CET
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of €189.75 billion as of November 7, 2025. Its market cap has increased by 0.49% in one year.
Market Cap
189.75B
Enterprise Value
194.55B
Revenue
37.37B
Ranking
n/a
PE Ratio
15.99
Stock Price
€109.02
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 189.75B, an increase of 29,722.27%. That is a compound annual growth rate of 10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 189.75B | 0.14% |
| Dec 31, 2024 | 189.49B | 9.61% |
| Dec 29, 2023 | 172.88B | -3.48% |
| Dec 30, 2022 | 179.12B | -15.60% |
| Dec 31, 2021 | 212.23B | 38.39% |
| Dec 31, 2020 | 153.36B | 12.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 48.17B |
| Merck KGaA | 47.59B |
| Fresenius SE & Co. KGaA | 26.83B |
| Bayer Aktiengesellschaft | 25.60B |
| Sartorius Aktiengesellschaft | 13.70B |
| Fresenius Medical Care AG | 11.99B |
| Fielmann Group AG | 3.72B |
| Carl Zeiss Meditec AG | 3.72B |